AIRLINK 212.80 Increased By ▲ 3.25 (1.55%)
BOP 10.34 Decreased By ▼ -0.12 (-1.15%)
CNERGY 7.25 Decreased By ▼ -0.10 (-1.36%)
FCCL 34.34 Decreased By ▼ -0.05 (-0.15%)
FFL 18.28 Increased By ▲ 0.23 (1.27%)
FLYNG 23.20 Increased By ▲ 0.28 (1.22%)
HUBC 130.50 Decreased By ▼ -1.99 (-1.5%)
HUMNL 14.21 Increased By ▲ 0.07 (0.5%)
KEL 5.04 Increased By ▲ 0.01 (0.2%)
KOSM 7.18 Increased By ▲ 0.11 (1.56%)
MLCF 44.76 Decreased By ▼ -0.44 (-0.97%)
OGDC 219.40 Increased By ▲ 1.02 (0.47%)
PACE 7.63 Increased By ▲ 0.05 (0.66%)
PAEL 41.95 Increased By ▲ 0.25 (0.6%)
PIAHCLA 17.47 Increased By ▲ 0.17 (0.98%)
PIBTL 8.70 Increased By ▲ 0.15 (1.75%)
POWERPS 12.50 No Change ▼ 0.00 (0%)
PPL 189.26 Increased By ▲ 0.23 (0.12%)
PRL 41.91 Decreased By ▼ -0.42 (-0.99%)
PTC 25.30 Increased By ▲ 0.13 (0.52%)
SEARL 103.60 Decreased By ▼ -0.36 (-0.35%)
SILK 1.05 Increased By ▲ 0.02 (1.94%)
SSGC 40.51 Increased By ▲ 1.27 (3.24%)
SYM 19.27 Increased By ▲ 0.11 (0.57%)
TELE 9.31 Increased By ▲ 0.07 (0.76%)
TPLP 12.78 Decreased By ▼ -0.32 (-2.44%)
TRG 69.50 Increased By ▲ 0.32 (0.46%)
WAVESAPP 10.68 Decreased By ▼ -0.04 (-0.37%)
WTL 1.71 No Change ▼ 0.00 (0%)
YOUW 4.22 Increased By ▲ 0.08 (1.93%)
BR100 12,142 Increased By 62.8 (0.52%)
BR30 36,730 Increased By 127.5 (0.35%)
KSE100 116,393 Increased By 340.7 (0.29%)
KSE30 36,681 Increased By 103 (0.28%)
Technology

Lab-grown blood vessels built from patient’s cells to make dialysis easier

Though dialysis is a common treatment for kidney disease, it is still far from pleasant. This is what researchers a
Published April 1, 2019

Though dialysis is a common treatment for kidney disease, it is still far from pleasant. This is what researchers are trying to change by growing human blood vessels in lab by the patient’s cells in order to make dialysis easier.

Researchers from Humacyte Inc., Duke University and Yale have created lab-grown human blood vessels from the patient’s own cells, which will replace synthetic polymers and donor tissues that carry risks of inflammation and immune system rejection.

The process of dialysis, as per Engadget, mimics some few of the kidney’s main functions, but it requires a machine that pulls out blood from a blood vessel, filters it and pumps it back into the body. An extra blood vessel, either synthetic or donated, is implanted into the patient’s arm that channels blood into the dialysis machine.

Newly created urea sorbent paves way for wearable artificial kidneys

In contrast to usual dialysis, the new method, which is already heading into clinical trials, would allow the patient’s own cells to create the extra blood vessel to be implanted in the arm.

The researchers lined a biodegradable polymer tube with vascular cells from a deceased donor. For eight weeks, the cells multiplied and formed a new tube while the polymer scaffolding broke down. The team then took the cellular tube and implanted it to the patient’s arm. The patients’ cells migrated into the tubes and multiplied to create mature blood vessels.

Out of 60 patients that participated, 13 showed that blood vessels developed into multi-layered tissues that self-healed after injury, effectively becoming like the person’s own blood vessels, reported New Scientist.

Moreover, these bioengineered vessels also showed no signs of scarring or inflammatory reactions. The researchers further hope to create large numbers of engineered blood vessels that doctors can essentially obtain ‘off-the-shelf’ for using in patients with various vascular diseases, including heart disease.

Copyright Business Recorder, 2019

Comments

Comments are closed.